Riot Platforms, Inc. (RIOT) delivered earnings and revenue surprises of -74.36% and +17.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Repay Holdings (RPAY) delivered earnings and revenue surprises of 0.00% and -1.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Quantum Computing Inc. (QUBT) delivered earnings and revenue surprises of 0.00% and +18.11%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -42.86% and +9.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Draganfly (DPRO) delivered earnings and revenue surprises of -118.18% and -41.23%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
GEN Restaurant Group, Inc. (GENK) delivered earnings and revenue surprises of 0.00% and +1.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Babcock & Wilcox (BW) delivered earnings and revenue surprises of +33.33% and +54.15%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Johnson Controls International (NYSE:JCI) just found a way to sell power that the data center industry was throwing away. On July 28, the company launched its Absorption Chiller Reference Design Guide, a blueprint that converts waste heat from on-site generators into cooling capacity, freeing up electricity that would otherwise go to running chillers. In a […]
Airbnb's platform is evolving.
Invesco sells you the same 100 stocks through two different funds at two different prices, and most investors buying the pricier one have no idea the cheaper version even exists.
In the closing of the recent trading day, Chewy (CHWY) stood at $22.59, denoting a -3.99% move from the preceding trading day.
Home Depot (HD) closed the most recent trading day at $350.78, moving 1.36% from the previous trading session.
In the most recent trading session, Deere (DE) closed at $609.28, indicating a -1.86% shift from the previous trading day.
In the most recent trading session, Intuit (INTU) closed at $334.43, indicating a +2.82% shift from the previous trading day.
Macy's (M) reached $24.9 at the closing of the latest trading day, reflecting a -1.97% change compared to its last close.
In the latest trading session, Workday (WDAY) closed at $184.19, marking a +2.53% move from the previous day.
Oracle (ORCL) reached $151.05 at the closing of the latest trading day, reflecting a +2.74% change compared to its last close.
In the closing of the recent trading day, Ulta Beauty (ULTA) stood at $548.66, denoting a -2.92% move from the preceding trading day.
Toll Brothers (TOL) concluded the recent trading session at $150, signifying a -3.28% move from its prior day's close.
The latest trading day saw Snowflake Inc. (SNOW) settling at $334.7, representing a +1.27% change from its previous close.
PDD Holdings Inc. Sponsored ADR (PDD) reached $93 at the closing of the latest trading day, reflecting a +1.35% change compared to its last close.
Marvell Technology (MRVL) closed at $208.61 in the latest trading session, marking a -4.62% move from the prior day.
In the closing of the recent trading day, Lowe's (LOW) stood at $218.8, denoting a -2.04% move from the preceding trading day.
Fed chair Kevin Warsh is focused on getting inflation to 2%.
The one-time Bitcoin miner posted a much deeper-than-expected net loss in its second quarter.
Power and water costs are becoming harder to ignore
AbCellera Biologics Inc. (NASDAQ:ABCL) rallied for a third consecutive day on Monday to hit a new three-year high, after its drug candidate for hot flashes in menopausal women achieved strong clinical trial results, sparking long-term rosy growth prospects. In intra-day trading, the stock surged to a record high of $10.01 before trimming gains to end […]
Advertiser demand is becoming harder for investors to ignore
The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, and pipeline candidates as Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) compete for dominance in one of healthcare’s fastest-growing markets. Yet another competitive advantage for investors to […]
Investors want proof that massive demand can produce cash flow